Official Title: Exploratory Study of MRI Biomarkers of NASH
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IRM-NASH
Brief Summary: Metabolic steatosis disease NAFLD is a rapidly growing disease in the world particularly in industrialized countries
NAFLD is defined by the presence of fatty liver disease This is a reversible phenomenon that can be estimated by non-invasive means such as ultrasound Non-invasive quantification on the other hand requires MRI
Nonalcoholic steatohepatitis NASH is the aggressive form of the disease that promotes the accumulation of fibrosis in the liver which can progress to cirrhosis and its complications
Currently there is no non-invasive biomarker of NASH and the diagnosis is based solely on liver biopsy
There is therefore a need for non-invasive biomarkers of NASH in patients with steatosis to diagnose NASH without the use of liver biopsy